PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
Autores:James D. Griffin, Thomas Meyer, Martha Wadleigh, Sarah Cohen, Jing Chen, Pamela S. Cohen, Johannes Roesel, Doriano Fabbro, Brian Huntly, Benjamin H. Lee, Daniel J. Deangelo, Sheng Xiao, Nicole Duclos, Jennifer Adelsperger, Lolita Banerj, Ilene Galinsky, Allison Coburn, Rachel Okabe, Ifor R. Williams, Jeffery L. Kutok